TNF Pharmaceuticals, Inc.
TNFA
$0.0625
-$0.0126-16.78%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -59.70% | 45.52% | -6.99% | 79.83% | 2.39% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 107.17% | -268.93% | 86.19% | -94.27% | -11.84% |
| Change in Net Operating Assets | -12.55% | -153.51% | 128.30% | -966.81% | -51.12% |
| Cash from Operations | 21.77% | -245.53% | 78.96% | -36.10% | -51.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.41% | 130.60% | -64.30% | 128.00% | -1,605.61% |
| Cash from Investing | -13.41% | 130.60% | -64.30% | 128.00% | -1,605.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | 100.00% |
| Total Dividends Paid | -- | -- | -- | -- | 100.00% |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -- | -- | -212.88% | -91.42% | 1,078.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 234.43% | 90.20% | -255.29% | 111.44% | 112.64% |